Point of Care Diagnostics Market to Reach USD 28,379.6 Million by 2026; Developing Healthcare facilities in India will Foster Growth, states Fortune Business Insights™

    NEXT STORY
    Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
    PREV STORY
    Sales of darolutamide started in the EU and Japan – Orion receives total of EUR 28 million milestones
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cascadian Therapeutics Announces FDA Orphan Drug Designation Granted to Tucatinib for the Treatment of HER2+ Metastatic Colorectal Cancer

    SEATTLE, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Microbiome Therapeutics: Global Markets

    author_avatar
    NASDAQ Market News

    G1 Therapeutics Announces Pricing of Initial Public Offering

    RESEARCH TRIANGLE PARK, N.C., May 16, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a ...

    author_avatar
    NASDAQ Market News